ArticleInternational journal of molecular sciences2022

GSK343, an Inhibitor of Enhancer of Zeste Homolog 2, Reduces Glioblastoma Progression through Inflammatory Process Modulation: Focus on Canonical and Non-Canonical NF-κB/IκBα Pathways.

Sarah Adriana Scuderi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.